REQUEST A DEMO
Total
USD $0.00
Search more companies

Santander Medical Group S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Santander Medical Group S.A.S Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Santander Medical Group S.A.S is based in Colombia. The head office is in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on September 23, 2015. It currently has a total number of 52 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 10.47% in 2023. There was a total negative growth of 19.24% in Santander Medical Group S.A.S’s total assets over the same period. In 2023, Santander Medical Group S.A.S’s net profit margin decreased by 13.64%.

Headquarters
Carrera 32 # 49 - 76
Bucaramanga; Santander;

Contact Details: Purchase the Santander Medical Group S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Santander Medical Group S.A.S report to view the information.
Outstanding Shares:
Purchase the Santander Medical Group S.A.S report to view the information.
Incorporation Date:
September 23, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Santander Medical Group S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
10.47%
Total operating revenue
10.47%
Operating profit (EBIT)
-10.5%
Net Profit (Loss) for the Period
-34.05%
Total assets
-19.24%
Total equity
-18.53%
Operating Profit Margin (ROS)
-7.4%
Net Profit Margin
-13.64%
Return on Equity (ROE)
-10.29%
Debt to Equity Ratio
-1.06%
Quick Ratio
-0.25%
Cash Ratio
0.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?